
53 – ICH Guidelines and Global Harmonization (S21E4)
About this episode
This is a dive into ICH guidelines, specifically E6(R2), which is a corner stone of current Good Clinical Practices, that shapes cGCP worldwide. We discuss the reasoning behind harmonization efforts and the way these standards are influencing national regulations.
This also discusses that ICH Guidelines, particularly the E6 R2 guideline, is about ensuring that clinical trials are conducted ethically. There is a focus on patient safety throughout every step. Practical implications for multinational trials and compliance strategies will be covered throughout this podcast episode.
Get every episode summarized
Each time From Concept to Medicine - A Comprehensive Drug Development Journey publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from From Concept to Medicine - A Comprehensive Drug Development Journey

21 Atorvastatin (S24E21)
From Concept to Medicine - A Comprehensive Drug Development Journey

185 - Episode 5 - Good Documentation Practices (GDP) in Medical Devices - The AL...
From Concept to Medicine - A Comprehensive Drug Development Journey

20 Liraglutide (S24E20)
From Concept to Medicine - A Comprehensive Drug Development Journey

18 Pioglitazone (S24E18)
From Concept to Medicine - A Comprehensive Drug Development Journey